Apyx Medical Corp Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Apyx Medical Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Apyx Medical Corp Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 34.6M shares, unchanged year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 34.6M +31 0% Nov 6, 2024 10-Q 2024-11-08
Q2 2024 34.6M +71 0% Aug 7, 2024 10-Q 2024-08-08
Q1 2024 34.6M +46.1K +0.13% Mar 19, 2024 10-K 2024-03-21
Q3 2023 34.6M +46K +0.13% Nov 8, 2023 10-Q 2023-11-09
Q2 2023 34.6M +70.8K +0.21% Aug 9, 2023 10-Q 2023-08-11
Q1 2023 34.6M +169K +0.49% Mar 15, 2023 10-K 2023-03-16
Q3 2022 34.6M +254K +0.74% Nov 9, 2022 10-Q 2022-11-10
Q2 2022 34.6M +250K +0.73% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 34.4M +111K +0.32% Mar 15, 2022 10-K 2022-03-17
Q3 2021 34.3M +69K +0.2% Nov 9, 2021 10-Q 2021-11-12
Q2 2021 34.3M +106K +0.31% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 34.3M +144K +0.42% Mar 29, 2021 10-K 2021-03-31
Q3 2020 34.3M +107K +0.31% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 34.2M +295K +0.87% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 34.2M +136K +0.4% Mar 27, 2020 10-K 2020-03-31
Q3 2019 34.2M +965K +2.91% Nov 11, 2019 10-Q 2019-11-15
Q2 2019 33.9M +718K +2.16% Jul 29, 2019 10-Q 2019-08-07
Q1 2019 34M +1.02M +3.08% Mar 11, 2019 10-K 2019-03-14
Q3 2018 33.2M +343K +1.04% Oct 29, 2018 10-Q/A 2020-05-08
Q2 2018 33.2M +2.34M +7.6% Jul 25, 2018 10-Q 2018-08-01
Q1 2018 33M +2.16M +7% Mar 9, 2018 10-K 2018-03-13
Q3 2017 32.9M +5.49M +20% Oct 30, 2017 10-Q 2017-11-03
Q2 2017 30.9M +3.67M +13.5% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 30.9M +3.81M +14.1% Mar 6, 2017 10-K 2017-03-10
Q3 2016 27.4M +179K +0.66% Oct 24, 2016 10-Q 2016-10-27
Q2 2016 27.2M 0 0% Jul 22, 2016 10-Q 2016-08-02
Q1 2016 27.1M +9.04M +50.2% Mar 16, 2016 10-K 2016-03-18
Q3 2015 27.2M +9.24M +51.5% Nov 4, 2015 10-Q 2015-11-05
Q2 2015 27.2M +9.28M +51.8% Aug 5, 2015 10-Q 2015-08-07
Q1 2015 18M +181K +1.02% Feb 26, 2015 10-K 2015-02-27
Q3 2014 18M +128K +0.72% Nov 10, 2014 10-Q 2014-11-10
Q2 2014 17.9M +96K +0.54% Aug 1, 2014 10-Q 2014-08-08
Q1 2014 17.8M +38.2K +0.22% Mar 14, 2014 10-K/A 2014-05-08
Q3 2013 17.8M +46.4K +0.26% Sep 20, 2013 10-Q/A 2013-09-25
Q2 2013 17.8M +38.7K +0.22% Aug 1, 2013 10-Q 2013-08-14
Q1 2013 17.8M +22.5K +0.13% Mar 4, 2013 10-K 2013-04-01
Q3 2012 17.8M +23.6K +0.13% Nov 1, 2012 10-Q 2012-11-14
Q2 2012 17.8M +35.1K +0.2% Aug 1, 2012 10-Q 2012-08-14
Q1 2012 17.8M Mar 1, 2012 10-K 2012-03-29
Q3 2011 17.8M Oct 10, 2011 10-Q 2011-11-14
Q2 2011 17.7M Jun 30, 2011 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.